An independent intelligence board aggregating credible research, preprints, clinical findings, biohacking experiments, and community discussions on therapeutic peptides, longevity science, and evidence-based anti-aging. Stories are scored for relevance, credibility, novelty, momentum, and practicality so the most important findings surface first.
A person reported on a forum that they started using GHK-Cu (a peptide) by injection once a day and then noticed they began getting frequent nosebleeds, something they’d had occasionally before but now much more often. They asked whether the new nosebleeds could be caused by the peptide, giving a bit of extra detail: 1 mg under the skin (subcutaneous), daily, and they’re a 38-year-old man. That’s the whole news item — a single-person observation, not a formal study. GHK-Cu is a small peptide (a short chain of amino acids) that naturally occurs in the body and binds copper; people sometimes use a synthetic form because it’s been studied for wound healing, skin improvement, and anti-inflammatory effects. In plain terms: it’s a molecule your body makes that researchers think can help with repair and skin health. It is not the same kind of drug as Ozempic (which affects appetite and blood sugar). GHK-Cu is typically used experimentally or off-label and isn’t an approved treatment for nosebleeds. What this report actually shows is an anecdote — one person noticing a temporal link between starting GHK-Cu and an increase in nosebleeds. That’s a weak kind of evidence. It doesn’t prove the peptide caused the bleeds. We don’t know whether other things changed at the same time: climate, allergies, nasal dryness, medications (aspirin, blood thinners), nasal trauma, or even placebo/nocebo effects. There are no controlled data here: no comparison group, no medical exam, and no lab tests. In short, interesting but not definitive. Why it matters: people experimenting with peptides want to know safety and side effects. If GHK-Cu could increase bleeding risk, that would be relevant for anyone with fragile nose vessels, on blood thinners, or with bleeding disorders. For most readers, the practical takeaway is to pay attention to timing, stop the product if the problem starts or worsens, and seek medical advice — especially if bleeding is heavy, prolonged, or new and unexplained. Caveats and risks: nosebleeds in winter are common because dry air irritates the nasal lining. Other contributors include allergies, nasal sprays, recent nose picking or blowing, high blood pressure, and medications that affect clotting. GHK-Cu has been studied mostly in lab and small clinical settings for skin and wound healing; it is not widely regulated as a prescription drug for most uses. We don’t have high-quality evidence that it causes bleeding. If someone experiences recurrent or severe nosebleeds after starting any new compound, they should stop using it and see a healthcare professional, and mention any other drugs or conditions. Don’t assume a single anecdote proves a causal link. Bottom line: interesting signal from one person, but not proof — get checked and be cautious until better data exist.
Source: r/Peptides